Hematological implications of covid 19 infection: importance of early decision making in patient´s prognosis
Implicaciones hematológicas de infección por COVID19: importancia de toma de decisiones tempranas con respecto al curso pronóstico
Article Sidebar
PDF (Español (España))
FLIP
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Main Article Content
In December 2019, a disease caused by Coronavirus (COVID 19) was identified. This infectious disease is associated with the development of severe acute respiratory syndrome (SARS-CoV-2). The first case occurred in the city of Wuhan, Hubei province, China. On January 30, 2020. The WHO declared it a public health emergency. On February 14th-2020, thousands of infections and associated deaths were identified, changing their status from emergency to pandemic. From this date until present, a great number of publications, research, as well as economic and human resources have been directed towards this pandemic in order to win a race against time, in which thousands of lives are lost every day, impacting the different axes both at a social, psychological and economic level.
Downloads
Article Details
Harapan H. et al. Coronavirus Disease 2019 (COVID-19): A Literature Review. J. Infect. Public Health. [Internet]. 2020;13:667-673. Disponible en: https://doi.org/10.1016/j.jiph.2020.03.019
Lu H, Stratton CW, Tang YW. Outbreak of Pneumonia of Unknown Etiology in Wuhan China: the Mystery and the Miracle. J Med Virol. [Internet]. 2020; 92(4):401–402. Disponible en https://doi.org/10.1002/jmv.25678
Gorbalenya AEA: Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. Biorxiv. [Internet]. 2020;(1)1-15. Disponible en http://dx.doi.org/10.1038/s41564-020-0695-z
Hui DS, E IA, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, McHugh TD, Memish ZA, Drosten C et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. [Internet]. 2020;91:264-266. Disponible en: https://doi.org/10.1016/j.ijid.2020.01.009
Bikdeli B, Madhavan, M, Jiménez D, et al. Covid 19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. J Am Coll Cardiol. [Internet]. 2020;75(23): 2950–2973. Disponible en: https://doi.org/10.1016/j.jacc.2020.04.031
Marcel L. Disseminated intravascular coagulation: An update on pathogenesis and diagnosis. Rev Hematol. [Internet]. 2018;11(8):663-672. Disponible en: https://doi.org/10.1080/17474086.2018.1500173
Burrell C, Howard C, Murphy F. Fenner and White's Medical Virology. 5th Edition. United States: Academic Press; 2016.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. [Internet]. 2020; 395(10224):565-574. Disponible en: https://doi.org/10.1016/s0140-6736(20)30251-8
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. [Internet]. 2020;579(7798):270-273. Disponible en: https://doi.org/10.1038/s41586-020-2012-7.
Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost. [Internet]. 2019;17:1989-1994: Disponible en: https://doi.org/10.1111/jth.14578
Lippi G, Favaloro EJ. D-dimer is associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis. J Thromb Haemost. [Internet]. 2020;120(5):876-878: Disponible en https://doi.org/10.1055/s-0040-1709650
Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. [Internet]. 2020:58(7):1131-1134. Disponible en: https://doi.org/10.1515/cclm-2020-0198
Gao Y, Li T, Han M, et al. Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID-19. J Med Virol. [Internet]. 2020;92(7):791:796. Disponible en: https://doi.org/10.1002/jmv.25770
Zhang Y, Xiao M, Zhang S et al. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. [Internet]. 2020;382:e38. Disponible en: https://doi.org/10.1056/nejmc2007575
Wang T, Chen R, Liu C et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. [Internet]. 2020;7(5):e362-e363: Disponible en: https://doi.org/10.1016/s2352-3026(20)30109-5.
Trybala E, Liljeqvist JA, Svennerholm B, Bergstrom T. Herpes Simplex Virus Types 1 and 2 Differ in Their Interaction with Heparan Sulfate. J. Virol. [Internet]. 2000;74(19):9106-9114. Disponible en: https://doi.org/10.1128/jvi.74.19.9106-9114.2000.
Vicenzi, E. et al. Coronaviridae and SARS-associated Coronavirus Strain HSR1. Emerg Infect Dis. [Internet]. 2004;10(3):413-8. Disponible en: https://doi.org/10.3201/eid1003.030683
Jin, L. et al. The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci. [Internet]. 1997;94(26):14683–14688. Disponible en: https://doi.org/10.1073/pnas.94.26.14683.
